Storgard Chris 4
4 · Design Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Storgard Chris
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2026-01-02+250,000→ 250,000 totalExercise: $9.10Exp: 2036-01-01→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.